IBM and the Broad Institute will codevelop algorithms to apply artificial intelligence to predict cardiovascular risk from genomic and clinical data.
Stat News reports that the head of IBM Watson Health is leaving her post.
Stat News reports that IBM's Watson supercomputer sometimes gives inappropriate cancer treatment advice.
IBM's supercomputing platform will continue to provide AI support to advanced cancer patients at VA medical centers for at least another year.
Genome Medical will use the proceeds of its Series A-1 financing to expand its nationwide footprint, as well as to invest in its telegenomics platform.
The Martinos Center, Envision Genomics, and startup RowAnalytics are building an open precision medicine platform called Giro Health on IBM architecture.
At the Cleveland Clinic Medical Innovation Summit, experts discussed the promise and challenges of genomic and health data, and strategies for taming it.
By analyzing EMRs and genomic data, Mendel Health believes its AI platform can identify patients for ongoing trials and help clinicians select treatments.
Stat News reports that IBM's Watson for Oncology isn't yet living up to its promise.
The newly announced Microbiome Immunity Project seeks to discover links between autoimmune diseases and bacteria in and on the human body.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.